OcellO
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of OcellO's published strategy and is not endorsed by, or produced in cooperation with, OcellO.
Strategic priorities
OcellO operates across 4 stated priorities, with the most concrete near-term plan anchored on exploring complex biology together.
Co-creation of automated workflows combining industry expertise with advanced instrumentation like ImageXpress HCS.ai to open complex biological systems and increase throughput for therapeutic breakthroughs.
Democratizing human-relevant research models through PDO expansion services and strategic acquisitions (Cellesce) to reduce the historical 90% attrition rate of drug candidates in clinical trials.
Deploying AI and machine learning as foundational infrastructure for modern laboratories, utilizing CellXpress.ai for automated decision-making and IN Carta for durable image analysis.
-
01
Exploring Complex Biology Together
Co-creation of automated workflows combining industry expertise with advanced instrumentation like ImageXpress HCS.ai to open complex biological systems and increase throughput for therapeutic breakthroughs.
-
02
Shifting Paradigms Together
Democratizing human-relevant research models through PDO expansion services and strategic acquisitions (Cellesce) to reduce the historical 90% attrition rate of drug candidates in clinical trials.
-
03
Transforming Science Together
Deploying AI and machine learning as foundational infrastructure for modern laboratories, utilizing CellXpress.ai for automated decision-making and IN Carta for durable image analysis.
-
04
Validating Next-Gen Therapeutics Together
Providing rigorous validation and data integrity for cell and gene therapies through traceable, audit-ready hardware meeting FDA 21 CFR Part 11 and EudraLex Annex 11 requirements.
Challenges we see
- R&D Operations Labor and Manufacturing
The Organoid "Scalability Cliff"
While 3D models like organoids offer superior biological relevance, 75% of customers express interest but technical hurdles of consistent cultivation remain the single greatest barrier to high-throughput application.
Reliance on manual labor for cell seeding, feeding, and passaging introduces unacceptable variability and undermines large-scale drug screens.
- IT Infrastructure Digital
Joining records across systems
Laboratory equipment such as bioreactors, spectrophotometers, and high-content imagers frequently operate as "data islands" with disconnected digital feedback loops.
Scientists spend approximately 65% of their time on manual data collection and reconciliation, creating "process blind spots" that slow root cause identification during scale-up.
- Compliance Regulatory
Regulatory Audit Vulnerability and Data Integrity
In GxP environments, maintaining "zero-error" audit trails for electronic records as required by FDA 21 CFR Part 11 and EudraLex Annex 11 becomes increasingly difficult with paperless processing.
Any lapse in standards or inability of a signer to be permanently linked to a record can result in catastrophic quality control failure and loss of commercialization leadership.
- Human Capital Labor
Workforce Digital Literacy Gap
The transition from "Biotech" to "TechBio" requires a cultural shift, with 57% of laboratory respondents identifying lack of specialized technological knowledge as the primary barrier to digital transformation.
Significant disconnect between leadership's vision for an "AI-driven laboratory" and actual team capabilities slows execution of programs like "Vision 2030".
- Technology Implementation Digital
Legacy Systems Integration
Many high-value laboratory and manufacturing assets utilize outdated interfaces like RS-232 or Profibus that are not natively compatible with modern cloud architectures.
These "legacy asset blindspots" block real-time monitoring, forcing higher CAPEX for replacement rather than modernization and blocking "Facility of the Future" connectivity.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Manual QC and Biological Variability
Laboratory technicians rely on manual tasks such as visual colony counting and pipetting, which are slow, error-prone, and introduce significant variability between researchers.
Implementation of AI vision systems utilizing YOLOv8 can automate detection and state classification of cells/organoids, counting 100+ instances per image in approximately one second with 90%+ accuracy.
-
Disconnected Digital Feedback
Valuable insights regarding strain performance or organoid development are lost because equipment operates in isolation, requiring manual data entry into Excel or paper logs.
Constructing an Integrated Operational Architecture using Data Gateways to capture streams directly from physical interfaces, enabling a "Source-to-Scientist" data work and reducing data collection time by 65%.
-
Training Lag for Lab Automation
The "Facility of the Future" requires technicians to operate sophisticated robotic systems like CellXpress.ai, but traditional training methods are slow and fail to prevent operator error.
Deploying AR and Digital Twin environments (e.g., Microsoft HoloLens) for immersive training, allowing technicians to conduct realistic protocols in virtual environments and reducing human error by 30%.
-
Regulatory Inefficiency and GxP Risk
Manually managing compliance for thousands of experimental cycles in a GxP environment is unsustainable and poses significant risk to regulatory approval timelines.
Transitioning to an ontology-driven data lakehouse with automated data pipelines ensures "zero-error" audit standards and data integrity from ingestion to final reporting, reducing report generation effort by 75%.
-
Paper Wall and Scaling Blind Spots
Significant R&D data remains on paper, creating a disconnect when scaling from lab-scale to industrial production and making it difficult to solve "Process Blind Spots".
Implementing a "Digital Lab" strategy with IoT retrofitting of existing R&D equipment to automatically log parameters and ensure full data lineage from flask to fermenter.
What we'd propose
- Digital Lab
Digital Lab (OPC UA & MTP Integration)
Comprehensive integration service that unifies diverse biological and analytical workflows into a cohesive digital ecosystem using industry-standard communication protocols.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
AI Vision & Lab Enhancement (YOLOv8)
Advanced software solutions tailored for biological process optimization using computer vision for high-speed cell counting and state detection.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Digital Manufacturing (IoT Retrofitting)
Hardware-software overlay service to digitize analog or legacy equipment, enabling real-time asset monitoring and predictive maintenance.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Industrial Data Platform (Ontology-Driven)
Standardized ontology-based architectures to unify R&D, manufacturing, and quality data into a single source of truth with automated compliance.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Immersive VR/AR Training & Human-Centric HMI
Virtual training environments and intuitive interfaces to minimize operator error and accelerate staff onboarding for complex lab automation.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what OcellO's own published ambition implies — not a perfect score.
- Data Interoperability 28 → 95
- Current: Reliance on manual data entry and "data islands" trapped in local machines. Target: Full MTP/OPC UA integration for unified, vendor-agnostic communication.
- Asset Connectivity 35 → 90
- Significant legacy infrastructure (RS-232/analog) is still air-gapped from cloud platforms; the target is full connectivity through IoT retrofitting of that equipment.
- Workforce Readiness 43 → 92
- Current: 57% skill gap exists; traditional training slow to adapt to new automation. Target: Digital-native team utilizing AR/VR for complex protocols.
- Process Intelligence 30 → 88
- Current: Data primarily used to analyze the past (reactive analysis). Target: Predictive modeling using digital twins and real-time AI vision (YOLOv8).
- Regulatory Compliance 55 → 100
- Current: Compliance maintained but through labor-intensive manual audit preparation. Target: Automated "zero-error" audit standards via ontology-driven platforms.
- Organoid Scalability 25 → 95
- Current: Manual "biological variability" prevents high-throughput screening. Target: Fully automated cell culture (CellXpress.ai) with AI-guided passaging.
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
Think we've read this right?
Talk to usRelated reading
-
Still biotech or already techbio?
The results of a Tech Imperatives for biotech 2022 report indicate changes in biotech production and management.
-
Lab of Tomorrow: We’re at a Turning Point – Is Your Lab on the Right Track?
Do you know what the biggest paradox is? Biotech and pharma fully understand that digitization is the future. Most of them know that effective market competition is simply not possible without artificial intelligence, automation, and data analysis. And yet, many labs are still stuck in the past, working in isolation, manually analyzing data, and losing the potential that technology offers.
-
Vision systems and foam detection
Machine vision systems enhance industrial safety and quality by detecting defects and foam in real time for efficient, automated processes.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with OcellO, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].